Masashi Kato Selected Research

Masashi Kato Research Topics

Disease

84	Neoplasms (Cancer) 02/2024 - 02/2004
45	Melanoma (Melanoma, Malignant) 02/2024 - 02/2004
24	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 05/2014
17	Atrial Fibrillation 12/2023 - 01/2018
16	Neoplasm Metastasis (Metastasis) 02/2024 - 05/2009
14	Lower Urinary Tract Symptoms 04/2021 - 01/2012
12	Hearing Loss (Hearing Impairment) 05/2020 - 08/2011
10	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2020 - 01/2013
9	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2023 - 05/2014
9	Overactive Urinary Bladder (Overactive Bladder) 01/2020 - 03/2008
9	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2019 - 01/2012
8	Heart Failure 07/2022 - 01/2019
7	Inflammation (Inflammations) 11/2023 - 10/2011
7	Pain (Aches) 08/2023 - 09/2002
6	Phototoxic Dermatitis (Phototoxicity) 08/2017 - 03/2013
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2023 - 01/2019
5	Carcinoma (Carcinomatosis) 07/2022 - 03/2013
5	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2011
5	Breast Neoplasms (Breast Cancer) 12/2021 - 11/2008
5	Urinary Incontinence 04/2021 - 01/2019
4	Infections 02/2024 - 11/2017
4	Margins of Excision 02/2024 - 05/2014
4	Carcinogenesis 01/2022 - 06/2010
4	Body Weight (Weight, Body) 01/2022 - 02/2015
4	Stroke (Strokes) 01/2020 - 07/2014
4	Hyperpigmentation 08/2019 - 05/2007
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015 - 01/2011
3	Hypertension (High Blood Pressure) 05/2024 - 09/2023
3	Stomach Neoplasms (Stomach Cancer) 12/2023 - 12/2019
3	Hypersensitivity (Allergy) 09/2023 - 04/2007
3	Thrombosis (Thrombus) 06/2023 - 04/2014
3	Hypoxia (Hypoxemia) 01/2023 - 09/2016
3	Fibrosis (Cirrhosis) 12/2021 - 01/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2019 - 02/2009
3	Stress Urinary Incontinence 01/2019 - 07/2012
3	Vitiligo 01/2018 - 02/2004
3	Fatty Liver 09/2016 - 07/2014

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2002
21	ArsenicIBA 09/2023 - 03/2003
11	Biomarkers (Surrogate Marker)IBA 03/2023 - 08/2011
10	Phosphotransferases (Kinase)IBA 01/2020 - 04/2002
8	CytokinesIBA 09/2020 - 03/2005
8	Drinking WaterIBA 01/2019 - 10/2012
7	Prostate-Specific Antigen (Semenogelase)IBA 07/2022 - 10/2015
7	silodosin FDA Link 04/2021 - 02/2016
6	Hormones (Hormone)IBA 10/2023 - 11/2016
6	MetallothioneinIBA 12/2016 - 02/2004
6	LigandsIBA 01/2016 - 05/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2015 - 06/2012
6	Tyrosine (L-Tyrosine)FDA Link 03/2012 - 05/2007
5	AntigensIBA 02/2024 - 11/2008
5	enzalutamideIBA 10/2023 - 09/2020
5	Tadalafil (Cialis)FDA Link 04/2021 - 01/2018
5	InterleukinsIBA 01/2018 - 03/2005
5	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 01/2008
5	Endothelin Receptors (Endothelin Receptor)IBA 01/2015 - 01/2010
4	SteroidsIBA 02/2024 - 12/2018
4	IronIBA 11/2023 - 03/2013
4	Androgen Receptors (Androgen Receptor)IBA 10/2023 - 01/2020
4	AndrogensIBA 07/2022 - 01/2020
4	Docetaxel (Taxotere)FDA Link 02/2021 - 10/2015
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2007
4	Cysteine (L-Cysteine)FDA Link 01/2020 - 09/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 10/2004
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 06/2012
4	BariumIBA 01/2016 - 01/2011
3	EnzymesIBA 02/2024 - 09/2016
3	Interleukin-10 (Interleukin 10)IBA 02/2024 - 07/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 01/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2012
3	Therapeutic UsesIBA 10/2021 - 09/2017
3	Hemoglobins (Hemoglobin)IBA 09/2021 - 02/2016
3	AlbuminsIBA 01/2020 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 01/2008
3	Melanins (Melanin)IBA 01/2019 - 02/2004
3	ManganeseIBA 09/2018 - 11/2016
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018 - 06/2012
3	Proto-Oncogene Proteins c-retIBA 11/2017 - 05/2010
3	Dutasteride (Avodart)FDA Link 10/2017 - 08/2014
3	Estrogen ReceptorsIBA 01/2017 - 07/2015
3	CholesterolIBA 09/2016 - 07/2014
3	Messenger RNA (mRNA)IBA 09/2016 - 05/2005
3	Neutral RedIBA 08/2015 - 12/2013
3	ChemokinesIBA 02/2015 - 09/2011
3	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2015 - 01/2014

Therapy/Procedure

36	Therapeutics 02/2024 - 02/2004
15	Catheter Ablation 11/2023 - 01/2018
12	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 05/2014
11	Castration 02/2024 - 10/2015
10	Drug Therapy (Chemotherapy) 12/2023 - 03/2005
8	Palliative Care (Palliative Therapy) 01/2020 - 11/2011
7	Immunotherapy 02/2024 - 02/2004
6	Conservative Treatment 06/2023 - 11/2017
5	Radiotherapy 07/2022 - 11/2017
5	Nephrectomy 01/2022 - 02/2009
3	Gastrectomy 12/2023 - 12/2019
3	Renal Dialysis (Hemodialysis) 09/2023 - 01/2006
3	Aftercare (After-Treatment) 01/2022 - 01/2018
3	Neoadjuvant Therapy 01/2022 - 05/2014
3	Transcatheter Aortic Valve Replacement 01/2021 - 01/2019